Site Help. How to find information and articles on cancer-current?

How this site works and tips on how to use the search.

We have past six months working hard to make the site even clearer to get. If you find errors please give them to us by so we can recover. The site functions as described herein.

How to find the information you need on our new website?

With a different outlook and changed menu structure we present an updated cancer-current. . Thus we hope...



Lees verder ...

FAQ - Frequently Asked Questions

Here are some frequently asked questions. I did this over the past months and where necessary supplemented. Some questions and answers there for 10 years and were not uptodate. If you find errors or have more recent information regarding the questions please email us and we will adjust. For most questions, and articles you can also comment, comment. This removes the forum.

New questions can be sent to redactie@kanker-actueel.nl and the webmaster will be posted after review with...

Lees verder ...

Questions

FAG - Frequently Asked Questions
Experiences of cancer patients with complementary approaches can be found by experience stories on our website and there are also some videos of experiences of cancer patients with complementary approaches to see. On the website of the SNFK his education films shown on complementary approaches to cancer.

If you want to support us you can do so through a donation anonymous or not. Any amount is welcome no...

Lees verder ...

Hyperthermia: BSD open phase III study for patients with pancreatic cancer. Study is conducted with chemo - cisplatin and gemcitabine with gemcitabine alone copy 1

October 31, 2012: People often ask me whether hyperthermia also works with pancreatic cancer. I can answer in the affirmative, see related articles below hyperthermia . But last year a Phase III study initiated where you perhaps can register for both AMC - Amsterdam Daniel den Hoed, Rotterdam, have good contacts with BSD because they also work with equipment from BSD, as Dr. Issels with BSD equipment.

February 21, 2012: Source: Press Release from BSD

BSD...

Lees verder ...

Uterine cervical cancer and

Uterine and cervical cancer

Information on current developments in both regular and alternative and / or complementary treatments and resources for uterine and cervical cancer at all stages. Over recent developments and also for complementary and alternative treatments for uterine and cervical cancer.

Uterine cancer and cervical cancer are often lumped together, thus suggesting that the same category of cancers would be. But this is a misconception. The origin, symptoms and treatments...



Lees verder ...

PDT-Photodynamic therapy to pancreatic cancer promising inoperabele. shows from different studies.

9 may 2012: more articles about PDT-Photo Dynamic therapy for pancreatic cancer can be found if you click here.

Photodynamic therapy promising for cancer of the pancreas (pancreatic cancer) Laurie Barclay, MD

Photodynamic therapy in normally inoperabele pancreatic cancer provides improved results with acceptable additional symptoms, according to a study published in the april issue of Gut. "Few pancreatic cancers are operable and few respond to chemo and/or irradiation", writes S.A.G. Brown and colleagues, of...

Lees verder ...

Interferon added to chemotherapy and radiation therapy prolongs life of selected patients with pancreatic

March 11, 2011: Source: Medscape and Society of Surgical Oncology (SSO) 64th Annual Cancer Symposium: Abstract   31. Presented March 4, 2011.

When interferon is added to chemotherapy and radiation can significantly prolong the life of pancreatic cancer patients who have been operated successfully and in good physical condition. This shows a small phase II study with 29 patients. The study was allowed because of the expected large randomized toxicity not be performed. In itself, this study provides promising...

Lees verder ...

Immunotherapies: GVAX pancreatic cancer vaccine and a-commenting on the molecular mesothelin gives hope in phase I trial in 14 patients and now gets support from FDA for further research.

11 april 2011: I am cancer-news to the revised and added to this article that have the FDA concerning the GVAX vaccine consent for further research within the scheme orphan medicines. At the bottom of this article State part of press release on research.

27 August: Source Dow: a vaccine against pancreatic cancer from the GVAX group of Cellgenesys gives hope thus results from a phase I trial. 14 patients received this vaccine after the regular treatments such as surgery and...

Lees verder ...

Diagnosis: CA19-9 significantly increased value indicates inoperabele pancreatic cancer and is doing better than surgery and diagnostic prevents unnecessary burdensome and costly surgical interventions.

7 may 2012: click here for article on Her2-Neu expression in pancreatic cancer that also could be a predictive factor for the treatment and the disease gradient of certain forms of pancreatic cancer.

Also Oncoline-pancreatic cancer has the guidelines for diagnosis and treatment of pancreatic cancer-pancreatic cancer by 2011 officially adjusted.

dated 23 October 2003:

Highly elevated CA19 values indicate inoperabele pancreatic cancer.

Despite the information obtained from CT scans and...





Lees verder ...

Thalidomide provides counter weight loss in Randomized placebo controlled study shows advanced pancreatic kankerpatiƫnten.

29 november 2005: source: Gut. 2005 Apr; 54 (4): 540-5.

Thalidomide (see also for positive effect of thalidomide in patients with Multiple Myeloma Kahler-) ensures counter weight loss in advanced pancreatic kankerpatiënten evidenced by Randomized placebo controlled study. The difference is statistically significant. The limited weight loss, first four weeks of administration took the weight even with the patients, makes for better quality of life. Here is the abstract of a small-scale randomized and placebo controlled study but so.

Source: Gut....



Lees verder ...